The significance of progression-free survival as an endpoint in evaluating the therapeutic value of antineoplastic agents

Por Maroun, J.A.
Publicado em 2011

Granulomatous hepatitis in a patient with previously treated histiocytic lymphoma

Por Vandenberg, T. A., Maroun, J. A.
Publicado em 1985

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

Por Jonker, D J, Maroun, J A, Kocha, W
Publicado em 2000

Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F

Por Le François, B G, Maroun, J A, Birnboim, H C
Publicado em 2007

Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis

Por Hedley, D. W., Maroun, J. A., Espir, Michael L. E.
Publicado em 1975

Rational use of elemental and nonelemental diets in hospitalized patients.

Por Fairfull-Smith, R, Abunassar, R, Freeman, J B, Maroun, J A
Publicado em 1980

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada

Por Attard, C.L., Maroun, J.A., Alloul, K., Grima, D.T., Bernard, L.M.
Publicado em 2010

VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.

Por Evans, W. K., Eisenhauer, E., Hughes, P., Maroun, J. A., Ayoub, J., Shepherd, F. A., Feld, R.
Publicado em 1988

Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer

Por Gill, S., Berry, S., Biagi, J., Butts, C., Buyse, M., Chen, E., Jonker, D., Mărginean, C., Samson, B., Stewart, J., Thirlwell, M., Wong, R., Maroun, J.A.
Publicado em 2011

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

Por Maroun, J.A., Anthony, L.B., Blais, N., Burkes, R., Dowden, S.D., Dranitsaris, G., Samson, B., Shah, A., Thirlwell, M.P., Vincent, M.D., Wong, R.
Publicado em 2007

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Por Cutsem, E Van, Hoff, P M, Harper, P, Bukowski, R M, Cunningham, D, Dufour, P, Graeven, U, Lokich, J, Madajewicz, S, Maroun, J A, Marshall, J L, Mitchell, E P, Perez-Manga, G, Rougier, P, Schmiegel, W, Schoelmerich, J, Sobrero, A, Schilsky, R L
Publicado em 2004